Dolton, Garry, Thomas, Hannah, Tan, Li Rong, Rius Rafael, Cristina ORCID: https://orcid.org/0000-0002-1896-1649, Doetsch, Stephanie, Ionescu, Giulia-Andreea, Cardo, Lucia F., Crowther, Michael D., Behiry, Enas, Morin, Théo, Caillaud, Marine E., Srai, Devinder, Parolini, Lucia, Hasan, Md Samiul, Fuller, Anna, Topley, Katie, Wall, Aaron, Hopkins, Jade R., Omidvar, Nader, Alvares, Caroline ORCID: https://orcid.org/0000-0003-4391-9802, Zabkiewicz, Joanna ORCID: https://orcid.org/0000-0003-0951-3825, Frater, John, Szomolay, Barbara ORCID: https://orcid.org/0000-0002-5375-5533 and Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135 2025. MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chain. The Journal of Clinical Investigation 135 (1) , e181895. 10.1172/JCI181895 |
Halilovic, Melisa, Abdelsalam, Mohamed, Zabkiewicz, Joanna ORCID: https://orcid.org/0000-0003-0951-3825, Lazenby, Michelle, Alvares, Caroline ORCID: https://orcid.org/0000-0003-4391-9802, Schmidt, Matthias, Brenner, Walburgis, Najafi, Sara, Oehme, Ina, Hieber, Christoph, Zeyn, Yanira, Bros, Matthias, Sippl, Wolfgang and Krämer, Oliver H. 2024. Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins. Leukemia 38 , pp. 2561-2572. 10.1038/s41375-024-02405-5 |
Jonas, Brian A., Hou, Jing-Zhou, Roboz, Gail J., Alvares, Caroline L. ORCID: https://orcid.org/0000-0003-4391-9802, Jeyakumar, Deepa, Edwards, John R., Erba, Harry P., Kelly, Richard J., Röllig, Christoph, Fiedler, Walter, Brackman, Deanna, Siddani, Satya R., Chyla, Brenda, Hilger-Rolfe, Jacqueline and Watts, Justin M. 2023. A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia. Hematological Oncology 41 (4) , pp. 743-752. 10.1002/hon.3159 |
Chiriches, Claudia ORCID: https://orcid.org/0000-0003-3758-1892, Nicolaisen, Nathalie, Wieske, Maria, Elhaddad, Heba, Mehmetbeyoglu, Ecmel, Alvares, Caroline ORCID: https://orcid.org/0000-0003-4391-9802, Becher, Dörte, Hole, Paul, Ottmann, Oliver Gerhard ORCID: https://orcid.org/0000-0001-9559-1330 and Ruthardt, Martin ORCID: https://orcid.org/0000-0003-1021-3811 2022. Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. PLoS Genetics 18 (10) , e1010463. 10.1371/journal.pgen.1010463 |
Zabkiewicz, Joanna ORCID: https://orcid.org/0000-0003-0951-3825, Lazenby, Michelle, Edwards, Gareth, Bygrave, Ceri A., Omidvar, Nader, Zhuang, Lihui, Knapper, Steve ORCID: https://orcid.org/0000-0002-6405-4441, Guy, Carol, Hills, Robert K. ORCID: https://orcid.org/0000-0003-0166-0062, Burnett, Alan K. and Alvares, Caroline L. ORCID: https://orcid.org/0000-0003-4391-9802 2020. Combination of a mitogen‐activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion‐based residual disease and prevents re‐expansion of FLT3 ‐ITD acute myeloid leukaemia. British Journal of Haematology 191 (2) , pp. 231-242. 10.1111/bjh.16665 |